Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PDE5A | O76074 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 1/20 | 0.37 |
| ▸ | PARG | Q86W56 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7466508 | 0.83 | HPGD (0.55) | MEN1KMT2AHPGDALDH1A1CYP3A4 | |
| SCHEMBL9392329 | 0.74 | PARG (0.37) | HPGDPARGKDM4EALDH1A1CYP3A4 | |
| SCHEMBL4766008 | 0.73 | KMT2A (0.54) | HTTMEN1KMT2APDE5AGRIN1 | |
| SCHEMBL21911678 | 0.72 | ALDH1A1 (0.39) | KDM4EALDH1A1CYP3A4 | |
| SCHEMBL29499309 | 0.71 | ADORA2A (0.43) | MEN1KMT2AHPGDALDH1A1ADORA3 | |
| SCHEMBL5478056 | 0.71 | KDM4E (0.35) | KDM4E | |
| SCHEMBL27124750 | 0.70 | PDE1B (0.32) | HTTHPGDKDM4EALDH1A1 | |
| SCHEMBL24406022 | 0.69 | ALDH1A1 (0.59) | HTTMEN1KMT2AGRIN1GRIN2B | |
| SCHEMBL10967101 | 0.68 | ALDH1A1 (0.46) | MEN1KMT2APDE5AKDM4EALDH1A1 | |
| SCHEMBL9392938 | 0.68 | TSHR (0.45) | HTTMEN1KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1678181-B1 | A2B ADENOSINE RECEPTOR ANTAGONISTS | CV THERAPEUTICS INC (US) | 2008-12-31 | — | — | EP | disclosed |